Quest Diagnostics Incorporated, a leading provider in the diagnostic testing industry, is headquartered in the United States. Founded in 1967, the company has established itself as a pivotal player in laboratory services, offering a comprehensive range of diagnostic information services that include clinical laboratory testing, anatomic pathology, and genetic testing. With a strong operational presence across North America, Quest Diagnostics is renowned for its commitment to innovation and quality, providing unique solutions that enhance patient care. The company has achieved significant milestones, including advancements in molecular diagnostics and a robust network of patient service centres. Recognised for its market leadership, Quest Diagnostics continues to set the standard in the healthcare sector, delivering reliable and accurate testing services that empower healthcare providers and patients alike.
How does Quest Diagnostics's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Quest Diagnostics's score of 32 is higher than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2022, Quest Diagnostics reported significant carbon emissions, totalling approximately 107,228,000 kg CO2e for Scope 1 and 91,613,000 kg CO2e for Scope 2. Their Scope 3 emissions were notably high, reaching about 820,410,000 kg CO2e. This indicates a substantial carbon footprint across their operations, particularly in Scope 3, which includes emissions from their supply chain and other indirect sources. In 2021, the company recorded Scope 1 emissions of approximately 238,910,000 kg CO2e and Scope 2 emissions of about 107,948,000 kg CO2e. The data from previous years, such as 2015 and 2016, shows a trend of emissions that highlights the ongoing challenge of reducing their carbon impact. Despite the lack of specific reduction targets or initiatives disclosed, Quest Diagnostics is actively monitoring and reporting their emissions across all three scopes. Their commitment to transparency in emissions reporting aligns with industry standards, although no specific science-based targets or climate pledges have been identified. Overall, Quest Diagnostics's emissions data underscores the importance of continued efforts in carbon management and reduction strategies to mitigate their environmental impact.
Access structured emissions data, company-specific emission factors, and source documents
2015 | 2016 | 2021 | 2022 | |
---|---|---|---|---|
Scope 1 | 83,929,000 | 00,000,000 | 000,000,000 | 000,000,000 |
Scope 2 | 145,724,000 | 000,000,000 | 000,000,000 | 00,000,000 |
Scope 3 | 41,299,000 | 00,000,000 | 000,000,000 | 000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Quest Diagnostics is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.